Nexien Biopharma Inc 's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nexien Biopharma Inc 's ROA in the third quarter of 2025?
Due to the lack of assets, it was not possible to calculate Nexien Biopharma Inc 's return on assets (ROA) in its third quarter of 2025

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) III. Quarter	(Dec 31 2024) II. Quarter	(Sep 30 2024) I. Quarter	(Jun 30 2024) IV. Quarter	(Mar 31 2024) III. Quarter
Y / Y Total Assets Change	-41.93 %	-50.27 %	-77.54 %	-90.31 %	-75.48 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	0	0	0
Return On Assets (TTM)	-4016.06 %	-3417.41 %	-3013.69 %	-2216.99 %	-1199.24 %
NXEN's Total Ranking	# 4990	# 5733	# 5113	# 5172	# 5229
Total Assets (TTM) in million	0	0	0	0	0
Seq. Total Assets Change	531.48 %	-73.51 %	18.41 %	-70.68 %	440.83 %
Seq. Net Income Change	-	-	-	-	-

NXEN's 5 Years Annual ROA >> Back to NXEN Management Effectiveness >> Compare NXEN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 500
Sector	# 1018
Overall	# 4909

Return On Assets Statistics
High	Average	Low
-140.03 %	-2014.69 %	-7368.31 %
(Sep 30 2018)		(Mar 31 2021)

Financial Statements
Nexien Biopharma Inc 's Assets	$ 0 million	NXEN's Balance sheet
Nexien Biopharma Inc 's Income	$ 0 million	Quarterly NXEN's Income Statement
NXEN's Income by Division		See NXEN's Income by Division

Annual Return On Assets	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022	(Jun 30 2021) FY 2021	(Jun 30 2020) FY 2020
Y / Y Total Assets Change	-90.31 %	-65.35 %	386.81 %	12.27 %	-92.67 %
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	-1	-2	-3
Annual Return On Assets	-5716.3 %	-838.63 %	-502.95 %	-7270.51 %	-11724.82 %

NXEN's 5 Years Annual ROA >> Back to NXEN Management Effectiveness >> Compare NXEN ROA to its Competitors

More Return On Assets Ratios
NXEN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NXEN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NXEN's Competitors
Subscribers only: Roa for Nexien Biopharma Inc 's Suppliers
Subscribers only: Return On Assets for NXEN's Customers

You may also want to know
NXEN's Roi	NXEN's Inventory Turnover Ratio	NXEN's Growth Rates	NXEN's Dividend Comparisons
	NXEN's Profitability Ratios	NXEN's Asset Turnover Ratio	NXEN's Dividend Growth
NXEN's Roe	NXEN's Valuation Ratios	NXEN's Financial Strength Ratios	NXEN's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.